Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Genetics|November 25, 2022
The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021Laura Roht, Mikk Tooming, Kadri Rekker, et al.
Pediatric Reports|January 21, 2026
Nationwide Study of Pediatric Drug-Resistant Epilepsy in Estonia: Lower Incidence and Insights into EtiologyStella Lilles, Klari Heidmets, Kaisa Teele Oja, et al.
Neurology International|May 26, 2026
Population-Based Study of Drug-Resistant Epilepsy Before Age Two: Predominance of Developmental and Epileptic EncephalopathiesStella Lilles, Klari Heidmets, Kaisa Teele Oja, et al.
Molecular Genetics & Genomic Medicine|March 2, 2023
AXIN2-related oligodontia-colorectal cancer syndrome with cleft palate as a possible new featureLaura Roht, Hanne K Hyldebrandt, Astrid T Stormorken, et al.
Acta Oncologica (Stockholm, Sweden)|May 18, 2026
Exploring the somatic mutational landscape of ovarian cancer in EstoniaMikk Tooming, Kadri Rekker, Kadri Toome, et al.
Cancers|July 29, 2023
The Prevalence and Molecular Landscape of Lynch Syndrome in the Affected and General PopulationLaura Roht, Piret Laidre, Mikk Tooming, et al.
Cancers|April 14, 2025
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk ScoresPeeter Padrik, Neeme Tõnisson, Tone Hovda, et al.
Frontiers in Genetics|August 8, 2022
Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical SettingHannes Jürgens, Laura Roht, Liis Leitsalu, et al.
Human Mutation|July 29, 2022
De novo putative loss-of-function variants in TAF4 are associated with a neuro-developmental disorderBeau D E Janssen, Marie-Jose H van den Boogaard, Klaske Lichtenbelt, et al.
Clinical Breast Cancer|October 30, 2025
Clinical Implementation Study of Genetic Risk-Based Breast Cancer ScreeningMadli Tamm, Peeter Padrik, Kristiina Ojamaa, et al.
Pageof 2